BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23664125)

  • 1. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.
    Morris MD; Neilands TB; Andrew E; Maher L; Page KA; Hahn JA
    Int J Drug Policy; 2017 Oct; 48():54-62. PubMed ID: 28804051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty.
    Rhodes T; Davis M; Judd A
    Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting.
    Bryant J; Brener L; Hull P; Treloar C
    Drug Alcohol Depend; 2010 Mar; 107(2-3):182-7. PubMed ID: 19942380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: a continuing concern.
    Habib SE; Lovejoy FH; Aspin C
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):823-34. PubMed ID: 12041560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
    Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
    Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
    N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staying safe from hepatitis C: engaging with multiple priorities.
    Harris M; Treloar C; Maher L
    Qual Health Res; 2012 Jan; 22(1):31-42. PubMed ID: 21873284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in injection risk behaviors at the first injection episode.
    Frajzyngier V; Neaigus A; Gyarmathy VA; Miller M; Friedman SR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):145-52. PubMed ID: 17276623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.
    Evans JL; Morris MD; Yu M; Page K; Hahn JA
    Drug Alcohol Depend; 2014 Sep; 142():239-44. PubMed ID: 25034898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hepatitis C testing in men who have sex with men, and associated risk behaviours, in Manchester, UK.
    Ireland G; Higgins S; Goorney B; Ward C; Ahmad S; Stewart C; Simmons R; Lattimore S; Lee V
    Sex Transm Infect; 2017 Sep; 93(6):404-409. PubMed ID: 28130506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection.
    Lea T; Mao L; Bath N; Prestage G; Zablotska I; de Wit J; Holt M
    AIDS Behav; 2013 May; 17(4):1344-51. PubMed ID: 23321949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions and deflections: associations between attitudes towards people with hepatitis C and testing for hepatitis C among Australian gay and bisexual men.
    Brener L; Ellard J; Murphy D; Callander D
    Sex Health; 2013 Jul; 10(3):268-74. PubMed ID: 23639110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practices of partnership: Negotiated safety among couples who inject drugs.
    Rance J; Rhodes T; Fraser S; Bryant J; Treloar C
    Health (London); 2018 Jan; 22(1):3-19. PubMed ID: 27491943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding HIV risks of chronic drug-using men who have sex with men.
    Rhodes F; Deren S; Wood MM; Shedlin MG; Carlson RG; Lambert EY; Kochems LM; Stark MJ; Falck RS; Wright-DeAgüero L; Weir B; Cottler L; Rourke KM; Trotter RT
    AIDS Care; 1999 Dec; 11(6):629-48. PubMed ID: 10716005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.